Loading clinical trials...
Loading clinical trials...
Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases
Conditions
Interventions
Experimental Group
Locations
1
United States
Pediatric Dermatology Clinic at Stanford Children's Hospital
Palo Alto, California, United States
Start Date
November 28, 2017
Primary Completion Date
December 30, 2024
Completion Date
December 31, 2024
Last Updated
February 13, 2024
NCT07470866
NCT00104325
NCT07388667
NCT07221448
NCT06637865
NCT07118891
Lead Sponsor
Joyce Teng
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions